Ardelyx Inc (ARDX)

NASDAQ
1.779
+0.059(+3.45%)
  • Volume:
    2,240,159
  • Day's Range:
    1.710 - 1.840
  • 52 wk Range:
    0.490 - 2.190

ARDX Overview

Prev. Close
1.72
Day's Range
1.71-1.84
Revenue
9.01M
Open
1.75
52 wk Range
0.49-2.19
EPS
-0.819
Volume
2,240,159
Market Cap
338.36M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
8,330,334
P/E Ratio
-2.23
Beta
1.47
1-Year Change
50.88%
Shares Outstanding
187,459,645
Next Earnings Date
Mar 08, 2023
What is your sentiment on Ardelyx Inc?
or
Vote to see community's results!

Ardelyx Inc News

Ardelyx Inc Analysis

Ardelyx Inc Company Profile

Ardelyx Inc Company Profile

Employees
86

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company’s lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Read More

Analyst Price Target

Average5.183 (+191.36% Upside)
High8
Low1.6
Price1.779
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyBuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral
  • And why is the volume showing zero?
    0
    • So, how high will we go today?
      0
      • aFerma
        0
        • it seems ARDX got an approval, since the price started increasing slowly.
          0
          • approval of ISBRELA confirmed
            0
            • Back to $8
              0
          • Info please... Why is this stock still stuck in the mud...
            0
            • After a long waiting, beautiful times are coming
              0
              • Up up $$$$$$$$$$$$$$$$$$$$$ up up
                0
                • What happen with this stock ?
                  0
                  • from -11% to -2 in some hours. boom
                    0